Literature DB >> 28401251

Delayed Myocardial Enhancement in Pediatric Hypertrophic Cardiomyopathy: Correlation with LV Function, Echocardiography, and Demographic Parameters.

Sonia El Saiedi1, Noha Hossam Behairy2, Ahmed Kharabish1, Reem Esmail1, Zeinab Salah Seliem1, Mervat Shafik1, Wesam El Mozy1.   

Abstract

Our aim was (1) to detect the presence of fibrosis by Cardiac magnetic resonance imaging (CMR) in the pediatric age group. (2) Correlate CMR findings with demographic data, LV function, and other echocardiographic parameters. We studied 40 pediatric patients diagnosed as HCM by echocardiography. All patients were subjected to clinical examination (in which the NYHA classification was determined for each patient), echocardiography, and CMR. CMR was done on a 1.5T Philips Achieva scanner in SSFP with delayed myocardial enhancement (DE-MRI). All demographic and functional parameters as well as pressure gradient across left ventricular outflow tract (LVOT) were correlated with the percentage of myocardial enhancement. We studied 13 female and 27 male patients from 45 days up to 18 years. The mean percentage of DE-MRI was 9.7 ± 9%. We found significant correlation between the NYHA classification and the pressure gradient across the LVOT (P = < 0.001) as well as the percentage of DE-MRI (P = 0.004). The percentage of DE-MRI showed positive correlation with LV myocardial mass index (P = 0.042). It didn't correlate with any other demographic or LV functional cardiac parameters. A good positive correlation was detected between the percentage of DE-MRI and the severity of pressure gradient across LVOT measured by echocardiography (r = 0.69 and P = <0.001). We found a significant correlation between the percentage of DE-MRI in children with HCM and the pressure gradient across LVOT, NYHA classification, and LV myocardial mass. This may help in the further management of those patients, planning for follow-up, and prognosis of the disease.

Entities:  

Keywords:  Cardiac magnetic resonance; Delayed enhancement; Hypertrophic cardiomyopathy; LV function

Mesh:

Year:  2017        PMID: 28401251     DOI: 10.1007/s00246-017-1612-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  32 in total

Review 1.  Detection of myocardial disorders by magnetic resonance spectroscopy.

Authors:  Lucy E Hudsmith; Stefan Neubauer
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-08

2.  Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Evan Appelbaum; Caitlin J Harrigan; Jacki Buros; C Michael Gibson; Connie Hanna; John R Lesser; James E Udelson; Warren J Manning; Barry J Maron
Journal:  Circ Heart Fail       Date:  2008-06-23       Impact factor: 8.790

3.  Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.

Authors:  Carsten Rickers; Norbert M Wilke; Michael Jerosch-Herold; Susan A Casey; Prasad Panse; Neeta Panse; Jochen Weil; Andrey G Zenovich; Barry J Maron
Journal:  Circulation       Date:  2005-08-09       Impact factor: 29.690

4.  Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.

Authors:  A Selcuk Adabag; Susan A Casey; Michael A Kuskowski; Andrey G Zenovich; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2005-03-01       Impact factor: 24.094

5.  Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry.

Authors:  Steven D Colan; Steven E Lipshultz; April M Lowe; Lynn A Sleeper; Jane Messere; Gerald F Cox; Paul R Lurie; E John Orav; Jeffrey A Towbin
Journal:  Circulation       Date:  2007-01-29       Impact factor: 29.690

6.  Remote magnetic navigation to guide endocardial and epicardial catheter mapping of scar-related ventricular tachycardia.

Authors:  Arash Aryana; Andre d'Avila; E Kevin Heist; Theofanie Mela; Jagmeet P Singh; Jeremy N Ruskin; Vivek Y Reddy
Journal:  Circulation       Date:  2007-02-12       Impact factor: 29.690

7.  Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy.

Authors:  James M Wilson; Rollo P Villareal; Ramesh Hariharan; Ali Massumi; Raja Muthupillai; Scott D Flamm
Journal:  Tex Heart Inst J       Date:  2002

8.  Right ventricular involvement in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Thomas H Hauser; Ethan Dubrow; Taylor A Horst; Kraig V Kissinger; James E Udelson; Warren J Manning
Journal:  Am J Cardiol       Date:  2007-08-09       Impact factor: 2.778

9.  Hypertrophic cardiomyopathy: prognostic factors and survival analysis in 128 Egyptian patients.

Authors:  Sonia A El-Saiedi; Zeinab S Seliem; Reem I Esmail
Journal:  Cardiol Young       Date:  2013-07-29       Impact factor: 1.093

Review 10.  Hypertrophic cardiomyopathy.

Authors:  Perry Elliott; William J McKenna
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

View more
  1 in total

Review 1.  What Aspects of Phenotype Determine Risk for Sudden Cardiac Death in Pediatric Hypertrophic Cardiomyopathy?

Authors:  Ingegerd Östman-Smith
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.